BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3031291)

  • 1. Leukotriene receptor antagonists. 1. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives.
    Marshall WS; Goodson T; Cullinan GJ; Swanson-Bean D; Haisch KD; Rinkema LE; Fleisch JH
    J Med Chem; 1987 Apr; 30(4):682-9. PubMed ID: 3031291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene receptor antagonists. 4. Synthesis and leukotriene D4/E4 receptor antagonist activity of 4-(alkyl)acetophenone derivatives.
    Gapinski DM; Roman CR; Rinkema LE; Fleisch JH
    J Med Chem; 1988 Jan; 31(1):172-5. PubMed ID: 2826785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives.
    Dillard RD; Carr FP; McCullough D; Haisch KD; Rinkema LE; Fleisch JH
    J Med Chem; 1987 May; 30(5):911-8. PubMed ID: 3033245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Phenylmethoxy)phenyl derivatives of omega-oxo- and omega-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists.
    Dillard RD; Hahn RA; McCullough D; Carr FP; Rinkema LE; Roman CR; Fleisch JH
    J Med Chem; 1991 Sep; 34(9):2768-78. PubMed ID: 1654427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships (SAR) of the 3-alkyl substituents among a series of hydroxy-acetophenone leukotriene antagonists.
    Marshall WS; Whitesitt CA; Goodson T; Roman C; Rinkema L; Fleisch JH
    Agents Actions; 1987 Aug; 21(3-4):275-7. PubMed ID: 3687580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship studies of a series of 5-aryl-4,6-dithianonanedioic acids and related compounds: a novel class of leukotriene antagonists.
    Perchonock CD; Uzinskas I; McCarthy ME; Erhard KF; Gleason JG; Wasserman MA; Muccitelli RM; DeVan JF; Tucker SS; Vickery LM
    J Med Chem; 1986 Aug; 29(8):1442-52. PubMed ID: 3016267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief review of preclinical and clinical studies with LY171883 and some comments on newer cysteinyl leukotriene receptor antagonists.
    Fleisch JH; Cloud ML; Marshall WS
    Ann N Y Acad Sci; 1988; 524():356-68. PubMed ID: 2837970
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of leukotriene receptor antagonists on isolated human intralobar airways.
    Buckner CK; Saban R; Castleman WL; Will JA
    Ann N Y Acad Sci; 1988; 524():181-6. PubMed ID: 2837953
    [No Abstract]   [Full Text] [Related]  

  • 9. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.
    Jones TR; Young R; Champion E; Charette L; Denis D; Ford-Hutchinson AW; Frenette R; Gauthier JY; Guindon Y; Kakushima M
    Can J Physiol Pharmacol; 1986 Aug; 64(8):1068-75. PubMed ID: 3024787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647.
    Marshall WS; Sigmund SK; Whitesitt CA; Lifer SL; Roman CR; Rinkema LE; Hahn RA; Fleisch JH
    Agents Actions; 1989 Jun; 27(3-4):309-12. PubMed ID: 2552762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity leukotriene receptor antagonists. Synthesis and pharmacological characterization of 2-hydroxy-3-[(2-carboxyethyl)thio]-3-[2-(8-phenyloctyl)phenyl] propanoic acid.
    Gleason JG; Hall RF; Perchonock CD; Erhard KF; Frazee JS; Ku TW; Kondrad K; McCarthy ME; Mong S; Crooke ST
    J Med Chem; 1987 Jun; 30(6):959-61. PubMed ID: 3035179
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
    Snyder DW; Giles RE; Keith RA; Yee YK; Krell RD
    J Pharmacol Exp Ther; 1987 Nov; 243(2):548-56. PubMed ID: 2824751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
    Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883.
    Rinkema LE; Roman CR; Russell WL; Spaethe SM; Bemis KG; Henry DP; Marshall WS; Fleisch JH
    J Pharm Pharmacol; 1990 Sep; 42(9):620-5. PubMed ID: 1706765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leukotriene effects of WY-50,295 tromethamine in isolated guinea pig pulmonary tissues.
    Heaslip RJ; Grimes D; Berkenkopf JW; Ilsemann BA; Sickels BD; Weichman BM
    Eur J Pharmacol; 1993 Apr; 234(2-3):247-54. PubMed ID: 8482329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonist.
    Young RN; Guindon Y; Jones TR; Ford-Hutchinson AW; BĂ©langer P; Champion E; Charette L; DeHaven RN; Denis D; Fortin R
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():37-45. PubMed ID: 3028100
    [No Abstract]   [Full Text] [Related]  

  • 17. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
    Mong S; Wu HL; Miller J; Hall RF; Gleason JG; Crooke ST
    Mol Pharmacol; 1987 Aug; 32(1):223-9. PubMed ID: 3039338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonistic action of DS-4574 against leukotrienes in guinea-pig smooth muscle.
    Aibara S; Mori M; Iwamoto T; Chiba T; Tsukada W
    Arch Int Pharmacodyn Ther; 1991; 314():147-59. PubMed ID: 1668601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist.
    Fleisch JH; Rinkema LE; Haisch KD; Swanson-Bean D; Goodson T; Ho PP; Marshall WS
    J Pharmacol Exp Ther; 1985 Apr; 233(1):148-57. PubMed ID: 3981452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 3H-leukotriene D4 binding to guinea pig lung receptors by the novel leukotriene antagonist ICI 198,615.
    Aharony D; Falcone RC; Krell RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):921-6. PubMed ID: 2826761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.